News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,522 Results
Type
Article (63905)
Company Profile (366)
Press Release (714251)
Section
Business (221035)
Career Advice (2995)
Deals (37870)
Drug Delivery (122)
Drug Development (87353)
Employer Resources (194)
FDA (17433)
Job Trends (16461)
News (375116)
Policy (36677)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (11)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (12)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (12)
2024 Biotech Beach Standard (8)
2024 Genetown Digital (5)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (7)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2963)
Academic (2)
Accelerated approval (2)
Adcomms (28)
Allergies (86)
Alliances (54107)
ALS (92)
Alzheimer's disease (1459)
Antibody-drug conjugate (ADC) (128)
Approvals (17408)
Artificial intelligence (268)
Autoimmune disease (17)
Automation (14)
Bankruptcy (392)
Best Places to Work (12444)
BIOSECURE Act (19)
Biosimilars (112)
Biotechnology (246)
Bladder cancer (63)
Brain cancer (28)
Breast cancer (265)
Cancer (2120)
Cardiovascular disease (183)
Career advice (2525)
Career pathing (33)
CAR-T (156)
Cell therapy (434)
Cervical cancer (20)
Clinical research (70340)
Collaboration (826)
Compensation (458)
Complete response letters (26)
COVID-19 (2827)
CRISPR (42)
C-suite (230)
Cystic fibrosis (103)
Data (1996)
Decentralized trials (2)
Denatured (34)
Depression (50)
Diabetes (266)
Diagnostics (6802)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (119)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (92)
Earnings (90288)
Editorial (39)
Employer branding (25)
Employer resources (164)
Events (122732)
Executive appointments (679)
FDA (18591)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (734)
Gene editing (108)
Generative AI (25)
Gene therapy (313)
GLP-1 (800)
Government (4938)
Grass and pollen (4)
Guidances (48)
Healthcare (20579)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (124)
Indications (27)
Infectious disease (2972)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (49)
Intellectual property (89)
Interviews (575)
IPO (17246)
IRA (50)
Job creations (4477)
Job search strategy (2095)
Kidney cancer (10)
Labor market (37)
Layoffs (519)
Leadership (20)
Legal (9082)
Liver cancer (76)
Lung cancer (313)
Lymphoma (137)
Machine learning (4)
Management (64)
Manufacturing (290)
MASH (67)
Medical device (14466)
Medtech (14471)
Mergers & acquisitions (21089)
Metabolic disorders (706)
Multiple sclerosis (76)
NASH (23)
Neurodegenerative disease (96)
Neuropsychiatric disorders (30)
Neuroscience (1988)
NextGen: Class of 2025 (7386)
Non-profit (5018)
Northern California (2470)
Now hiring (38)
Obesity (384)
Opinion (255)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (79)
Parkinson's disease (142)
Partnered (20)
Patents (217)
Patient recruitment (97)
Peanut (51)
People (63102)
Pharmaceutical (87)
Pharmacy benefit managers (19)
Phase I (21830)
Phase II (30782)
Phase III (23071)
Pipeline (1059)
Podcasts (85)
Policy (130)
Postmarket research (3081)
Preclinical (9524)
Press Release (72)
Prostate cancer (98)
Psychedelics (38)
Radiopharmaceuticals (262)
Rare diseases (393)
Real estate (6764)
Recruiting (74)
Regulatory (24772)
Reports (55)
Research institute (2617)
Resumes & cover letters (466)
Rett syndrome (3)
RNA editing (4)
RSV (45)
Schizophrenia (76)
Series A (130)
Series B (83)
Service/supplier (15)
Sickle cell disease (56)
Southern California (2149)
Special edition (16)
Spinal muscular atrophy (162)
Sponsored (31)
Startups (4035)
State (2)
Stomach cancer (16)
Supply chain (65)
The Weekly (48)
United States (22114)
Vaccines (757)
Venture capitalists (39)
Webinars (13)
Weight loss (276)
Women's health (36)
Worklife (18)
Date
Today (239)
Last 7 days (733)
Last 30 days (2894)
Last 365 days (35532)
2025 (8470)
2024 (37218)
2023 (42196)
2022 (53498)
2021 (58252)
2020 (57182)
2019 (50632)
2018 (38482)
2017 (35489)
2016 (35842)
2015 (41882)
2014 (35949)
2013 (31638)
2012 (33756)
2011 (34267)
2010 (33363)
Location
Africa (1008)
Alabama (51)
Alaska (7)
Arizona (247)
Arkansas (14)
Asia (44604)
Australia (8042)
California (5691)
Canada (1897)
China (503)
Colorado (257)
Connecticut (279)
Delaware (132)
Europe (99476)
Florida (835)
Georgia (204)
Hawaii (1)
Idaho (63)
Illinois (563)
India (26)
Indiana (306)
Iowa (9)
Japan (145)
Kansas (105)
Kentucky (25)
Louisiana (9)
Maine (60)
Maryland (885)
Massachusetts (4358)
Michigan (232)
Minnesota (395)
Mississippi (2)
Missouri (83)
Montana (29)
Nebraska (25)
Nevada (58)
New Hampshire (69)
New Jersey (1633)
New Mexico (31)
New York (1635)
North Carolina (1017)
North Dakota (8)
Northern California (2470)
Ohio (197)
Oklahoma (14)
Oregon (37)
Pennsylvania (1283)
Puerto Rico (10)
Rhode Island (28)
South America (1400)
South Carolina (19)
South Dakota (1)
Southern California (2149)
Tennessee (95)
Texas (852)
Utah (174)
Virginia (136)
Washington D.C. (64)
Washington State (537)
West Virginia (3)
Wisconsin (61)
778,522 Results for "emmaus life sciences formerly known as emmaus medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Emmaus Life Sciences Reports Delayed Filing of Annual Report
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported that the filing of its Annual Report on Form 10-K for the year ended December 31, 2023 will be delayed.
April 15, 2024
·
3 min read
Policy
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that it has received marketing authorization from the Puerto Rico Department of Health for Endari®.
February 2, 2024
·
4 min read
Press Releases
Emmaus Life Sciences Reports 2023 Financial Results
July 3, 2024
·
8 min read
Business
Emmaus Life Sciences Reports Management Changes
Emmaus Life Sciences, Inc. today reported that on August 18, 2023 the Board of Directors, including Yutaka Niihara, M.D., Ph.D, determined that Dr. Niihara would no longer serve as Chief Executive Officer of Emmaus, or as Chairman of the Board, in order to allow Dr. Niihara to pursue business opportunities in Ube, Japan and in India previously initiated by Emmaus.
August 23, 2023
·
5 min read
Biotech Beach
Emmaus Life Sciences Reports Q3 2023 Financial Results
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported on its financial condition and results of operations as of and for the three and nine months ended September 30, 2023.
November 14, 2023
·
8 min read
Business
Emmaus Life Sciences Reports Q2 2023 Financial Results
Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported on its financial condition and results of operations as of and for the three and six months ended June 30, 2023.
August 14, 2023
·
9 min read
Press Releases
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program
July 12, 2024
·
4 min read
Biotech Beach
Emmaus Life Sciences Receives Marketing Authorization for Endari® in Oman
Emmaus Life Sciences, Inc., a leader in sickle cell disease treatment, announced that it has received marketing authorization from the Oman Ministry of Health for the commercial distribution and sale of Endari® in the country to treat sickle cell disease in patients five years of age and older.
July 13, 2023
·
4 min read
Biotech Beach
Emmaus Life Sciences Provides Interim Shipment Data
Emmaus Life Sciences, Inc., a leader in sickle ell disease treatment, announced preliminary results for the 3 months ended March 31, 2023.
April 3, 2023
·
4 min read
Job Trends
Report: 2025 U.S. Life Sciences Salary Report
March 25, 2025
·
1 min read
·
BioSpace Insights
1 of 77,853
Next